Key facts
- Franceschini, Baiardi, Hughson, McKenzie, Moda, Rossi, Capellari, Green, Giaccone, Caughey, Parchi: Bologna group with RML (Caughey, Hughson), Edinburgh (Green) and Australia (McKenzie).
- Its neuropathology laboratory analysed consecutive diagnostic samples from January 2003 to June 2016 and is described as a major reference laboratory for prion disease in Italy.
- In that cohort CSF RT-QuIC had 82.1 percent sensitivity and 99.4 percent specificity.
- The program is directed by Piero Parchi (neuropathology of neurodegenerative diseases) and is linked to the University of Bologna.
- Its skin punch biopsy study (71 samples from 35 patients) reported about 89 percent sensitivity.
- Bologna co-authored the CSF plus olfactory mucosa RT-QuIC algorithm that reached virtually 100 percent sensitivity and specificity in the clinical phase.
Timeline
- 2003Start of the consecutive diagnostic sample series.
- 2017CSF and olfactory mucosa algorithm published.
- 2020Neuropathology program led by Parchi.
Sources for this page
- High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions (Sci Rep 2017; listed on Parchi publication page)
- Prion-specific and surrogate CSF biomarkers in CJD: diagnostic accuracy in relation to molecular subtypes (PMC5348556)
- University of Bologna: Piero Parchi curriculum vitae (English)
- Capellari, Caughey, Parchi: detection of prions in skin punch biopsies of CJD patients (Ann Clin Transl Neurol 2020)
- Bongianni et al.: diagnosis of human prion disease using RT-QuIC of olfactory mucosa and CSF (JAMA Neurology 2017; IRIS record)